BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36848089)

  • 1. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidentally Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer Screening in a Mississippi Delta Cohort.
    Liao W; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Ray MA; Faris NR; Pinsky PF; Smeltzer MP; Osarogiagbon RU
    J Thorac Oncol; 2024 Apr; 19(4):589-600. PubMed ID: 37984678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
    Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
    JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
    Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
    JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort.
    Osarogiagbon RU; Liao W; Faris NR; Meadows-Taylor M; Fehnel C; Lane J; Williams SC; Patel AA; Akinbobola OA; Pacheco A; Epperson A; Luttrell J; McCoy D; McHugh L; Signore R; Bishop AM; Tonkin K; Optican R; Wright J; Robbins T; Ray MA; Smeltzer MP
    J Clin Oncol; 2022 Jul; 40(19):2094-2105. PubMed ID: 35258994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.
    Burnett-Hartman AN; Carroll NM; Honda SA; Joyce C; Mitra N; Neslund-Dudas C; Olaiya O; Rendle KA; Schnall MD; Vachani A; Ritzwoller DP
    Ann Am Thorac Soc; 2022 Mar; 19(3):433-441. PubMed ID: 34543590
    [No Abstract]   [Full Text] [Related]  

  • 10. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
    Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
    Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
    Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
    Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.
    Kim HY; Jung KW; Lim KY; Lee SH; Jun JK; Kim J; Hwangbo B; Lee JS
    Cancer Res Treat; 2018 Jul; 50(3):748-756. PubMed ID: 28724283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
    J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3).
    Yang X; Dorrius MD; Jiang W; Nie Z; Vliegenthart R; Groen HJM; Heuvelmans MA; Sidorenkov G; Vonder M; Ye Z; de Bock GH
    Eur Radiol; 2022 Dec; 32(12):8162-8170. PubMed ID: 35678862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
    Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
    JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.